Science 371 , eabc0956 (2021)
Recently, GLP-1 was highlighted as a regulator of diverse pathways, but its potential as the therapeutic target of depressive disorder was not described comprehensively
Novo Nordisks Response to JAMA Study and Allegations In an emailed statement, Wegovy manufacturer Novo Nordisk countered that there were several limitations of the JAMA study design, which was not a randomized controlled trial, as reported by Reuters
Anti-inflammatory effects: Downregulates pro-inflammatory cytokines (IL-6, TNF-, IL-1) and reduces oxidative stress Gut barrier integrity: Promotes repair of tight junctions, limiting leaky gut and preventing translocation of inflammatory molecules Angiogenesis and collagen production: Enhances growth of new blood vessels and collagen fibers, accelerating tissue repair after injury or chronic inflammation How BPC-157 decreases inflammation 3 Suppresses pro-inflammatory pathways: Inhibits NF-B signaling, reducing the cascade of inflammatory cytokines Enhances anti-inflammatory factors: Upregulates protective growth factors such as VEGF (vascular endothelial growth factor) and TGF- Reduces oxidative stress: Neutralizes reactive oxygen species (ROS), decreasing tissue damage in the inflamed oral mucosa or stomach lining Restores tissue balance: Unlike broad anti-inflammatories (NSAIDs), BPC-157 doesnt shut down inflammation entirely
Combined with a well-formulated copper peptide serum, this creates a dual-pathway strategy: GHK-Cu provides the broad regenerative signal from the growth factor side, while Nanoretinol provides the targeted collagen-building signal from the retinoid side without either undermining the other
